Clinical Trial Update: A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and tolerability of MEDI-545 (injection) in patients with systemic lupus erythematosus has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MEDI-545

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2018-11-19